ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

Former CDRH Director Jeff Shuren’s thoughts on what Trump’s FDA cuts might mean for medical device companies: “Having robust science to inform decision making has really been the lifeblood for the agency. Patients and providers rely on the FDA to assure those devices are safe and effective.”

Apr 6, 2025, 9:20 PM

Record data

{
  "uri": "at://did:plc:cf7lbewebl77psm44bkkiuzn/app.bsky.feed.post/3lm6eri5a5c2h",
  "cid": "bafyreieriuxcufu7wda62xrfdqzc4ixe532xlbbjr2a5jh42ozlvsdp6uq",
  "value": {
    "text": "Former CDRH Director Jeff Shuren’s thoughts on what Trump’s FDA cuts might mean for medical device companies: “Having robust science to inform decision making has really been the lifeblood for the agency. Patients and providers rely on the FDA to assure those devices are safe and effective.”",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.medicaldesignandoutsourcing.com/former-cdrh-director-jeff-shuren-fda-layoffs-review-times/",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreihwr3pa753yy46spx7b7ll5n3b7h56bbgofdz6fftvzdj3fn4gfbe"
          },
          "mimeType": "image/jpeg",
          "size": 100376
        },
        "title": "Former CDRH Director Jeff Shuren on what FDA cuts might mean for device developers",
        "description": "\"It would not be surprising if we saw longer review times, at least in the near term,\" Shuren said about the FDA layoffs."
      }
    },
    "langs": [
      "en"
    ],
    "createdAt": "2025-04-06T21:20:04.560Z"
  }
}